Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

CVS Health Corp. buy Wolfe Research

Start price
€65.50
12.09.23 / 50%
Target price
€74.70
12.09.24
Performance (%)
-14.98%
Price
€53.27
11:45
Summary
This prediction is currently active. The prediction for CVS Health Corp. disappoints with a performance of -14.98%. Dividends of €2.42 are taken into consideration when calculating the performance. This prediction currently runs until 12.09.24. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this prediction

CVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.

Performance without dividends (%)
Name 1w 1m
CVS Health Corp. -3.050% -3.050%
iShares Core DAX® -0.116% 1.953%
iShares Nasdaq 100 -2.733% -1.273%
iShares Nikkei 225® -1.721% 3.263%
iShares S&P 500 -1.527% 0.194%

Comments by Wolfe_Research for this prediction

In the thread CVS Health Corp. diskutieren
Prediction Buy
Perf. (%) -14.98%
Target price 74.704
Change
Ends at 12.09.24

CVS Health Co. (NYSE: CVS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $80.00 price target on the stock.
Ratings data for CVS provided by MarketBeat